Wettig Thane's Form 4/A amendment
AmendedKyntra Bio, Inc. (KYNB) · filed May 19, 2026
- Accession no.
- 0001815638-26-000007
- Filed
- May 19, 2026
- Trade date
- May 14, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- May 18, 2026
This filing lists 1 non-derivative transaction. Open-market purchases total $19.9K. It was filed 5 days after the trade.
This amendment replaces 0001815638-26-000005 (filed May 18, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wettig ThaneCIK 0001815638 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 14, 2026 | Common Stock | PPurchaseAcquired | +2,800 | $7.09 | +$19,852 | 27,203 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
This amendment has no footnotes.
Remarks
This Form 4/A is being filed to correct the information in column 4 to indicate an acquisition of shares. The transaction was an open-market purchase and should have been reported as an acquisition ("A"), not as a disposition ("D"). No other changes are being made.